WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
Film executives on developing IPs and reaching global audiencesNorth Carolina boy, 18, wins $2million on one of the first scratchBroadchurch actress is unrecognisable as she transforms into a noHome appliance giant Midea reports 10 pct revenue increase in Q1I'm a flight attendantMan arrested in fatal shooting of Chicago police officer who was heading home from workLiberia passes a law setting up a longIRS acts to address wide disparity in audit rates between Black taxpayers and other filersSend us Patriots: Ukraine's battered energy plants seek air defenses against Russian attacksAnswering readers' questions about the protest movement on US college campuses